Hal Chapman
Clinical trials sponsored by Hal Chapman, explained in plain language.
-
Green tea compound tested as potential new treatment for scarred lungs
Disease control OngoingThis study is testing whether a purified compound from green tea, called EGCG, is safe for people with idiopathic pulmonary fibrosis (IPF), a serious lung scarring disease. It will involve about 50 patients who are already taking standard IPF medications. Researchers will give pa…
Phase: PHASE1 • Sponsor: Hal Chapman • Aim: Disease control
Last updated Apr 02, 2026 04:10 UTC
-
Green tea scan: tracking scarring in lungs
Knowledge-focused OngoingThis study is testing a new type of imaging scan to see if it can detect changes in lung scarring caused by a compound from green tea (EGCG). Up to 22 people with Idiopathic Pulmonary Fibrosis (IPF) will get two special PET scans to measure collagen in their lungs. The goal is to…
Phase: PHASE1 • Sponsor: Hal Chapman • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC